Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Omadacycline 0.002-32 µg/mL

K-Number: K182922 · 2018-12-14

Decision Date2018-12-14
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Omadacycline 0.002-32 µg/mL is the device name listed in this FDA 510(k) record. The listed applicant is Liofilchem s.r.l.. It received FDA 510(k) clearance on 2018-12-14 under 510(k) number K182922. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Omadacycline 0.002-32 µg/mL?

MTS Omadacycline 0.002-32 µg/mL is a medical device that received FDA 510(k) clearance on 2018-12-14. The listed applicant is Liofilchem s.r.l.. The 510(k) number is K182922.

When did MTS Omadacycline 0.002-32 µg/mL receive FDA 510(k) clearance?

MTS Omadacycline 0.002-32 µg/mL received FDA 510(k) clearance on 2018-12-14, under 510(k) number K182922.

Who is the listed applicant for MTS Omadacycline 0.002-32 µg/mL?

The FDA 510(k) record lists Liofilchem s.r.l. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MTS Omadacycline 0.002-32 µg/mL?

The FDA product code for MTS Omadacycline 0.002-32 µg/mL is JWY.

Other records listing Liofilchem s.r.l. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 35 devices →

Related Devices (Code: JWY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.